On June 16, 2023 Kintara Therapeutics, Inc. (Nasdaq: KTRA) ("Kintara" or the "Company"), a biopharmaceutical company focused on the development of new solid tumor cancer therapies, reported that its President and CEO, Robert E. Hoffman and its Chief Scientific Officer, Dennis Brown, Ph.D., will participate in a fireside chat at the Maxim Group Virtual Conference on Tuesday, June 20, 2023 at 4:30 pm ET (Press release, Kintara Therapeutics, JUN 16, 2023, View Source [SID1234632746]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The Conference will be live on M-Vest. To attend click here to reserve your seat